HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Npc209773

HCID 174174
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
16175-85-2
Standard SMILES
CN1[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2
InChIKey
RKUNBYITZUJHSG-SPUOUPEWSA-N
Molecular formula
C17H23NO3
Average molar mass
289.4 g/mol
Monoisotopic mass
289.1677936

Overview

Atropine is a racemate composed of equimolar concentrations of (S)- and (R)-atropine. It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. It has a role as an antidote to sarin poisoning, a oneirogen, a bronchodilator agent, an anti-arrhythmia drug, a muscarinic antagonist, a parasympatholytic, a mydriatic agent, an anaesthesia adjuvant and a plant metabolite. It contains a (S)-atropine and a (R)-atropine.

Names & identifiers

Preferred name
Npc209773
IUPAC
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
English name
Atropine
Molecular formula
C17H23NO3
Molecular weight
289.37

Names & synonyms

RefChem:1092872Npc209773ATROPINE51-55-8dl-HyoscyamineAtropenAtropinTropine tropatedl-TropyltropateAtropinolEyesulesIsopto-atropine
Show more names
d-hyoscyamineHSDB2199Atropisol
Troyl tropateAtropinaAtropin-flexiolen(+,-)-Tropyl tropateAtropin [German]Atropina [Italian]hyoscyamine(+/-)-Atropine

Database identifiers

CAS
16175-85-2、51-55-8
PubChem CID
174174
DTXSID
DTXSID4020113
ChEMBL
CHEMBL254656、CHEMBL475124
ChEBI
CHEBI:16684
UNII
7C0697DR9I、HA7DL7YA9K
Nikkaji
J1.385.555B、J1.566.306E

Properties

Computed structural propertiesFilling in

XLogP
1.8
Topological polar surface area
49.8 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
5
Heavy atoms
21
Formal charge
0
Complexity
353

Experimental & physicochemical properties

Solubility>43.4 [ug/mL] (The mean of the results at pH 7.4)
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Dissociation Constants · 3 items

9.84

9.84

9.43

Collision Cross Section171.5 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physicochemical properties

Melting point
115 · 115-118 °C
Boiling point
431.53 °C · 431.53°C (rough estimate)
Density
1.047 · 1.0470 (rough estimate)
refractive index
1.52 · 1.5200 (estimate)
Flash point
2 ℃ · 2℃
storage temp.
-20 °C · -20°C
solubility
2 O: · H2O: 2 mg/mL

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

F
8-10-23
wgk
3
tsca
TSCA listed
rtecs
CK0700000
ridadr
1544
hs_code
29399900
Toxicity
LD50 orally in rats: 750 mg/kg (Cahen, Tvede)
risk_code
26/28-36/37/38-20/21/22-36-11
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
T+,Xn,F
safety_code
25-45-36-26-36/37-16
hazard_class
6.1
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
packing_group
III
Hazard statements
H300+H330
Hazard Classifications
Acute Tox. 2 InhalationAcute Tox. 2 Oral
Precautionary statements
P260-P264-P270-P271-P284-P304+P340+P310
Hazardous Substances Data
51-55-8(Hazardous Substances Data)

Chemistry & industry

Pharmacology

ATC CodeA03BA01
Protein BindingThe protein binding of atropine ranges from 14% to 44%, and is saturable between 2 and 20 μg/mL.
Pharmacodynamics · 1 item

Atropine is an antimuscarinic agent that antagonizes the effects of acetylcholine. In small doses, atropine slows heart rate, and tachycardia develops due to paralysis of vagal control. Compared to [scopolamine], atropine has a more potent and prolonged effect on the heart, intestine and bronchial muscle, but a weaker effect on the iris, ciliary body and certain secretory glands. Atropine leads to increased respiratory rate and depth of respiration, possibly due to the drug-induced bronchiolar dilatation rather than its mild effect on vagal excitation. At an adequate dose, atropine abolishes different types of reflex vagal cardiac slowing or asystole. Atropine can be used to prevent or abolish bradycardia or asystole induced by the injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. When vagal activity is an etiologic factor, atropine may also lessen the degree of partial heart block. In clinical doses, atropine counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure. The use of topical atropine in the eye induces mydriasis by inhibiting the contraction of the circular pupillary sphincter muscle normally stimulated by acetylcholine. This results in the contraction of the countering radial pupillary dilator muscle and pupil dilation. The use of atropine may precipitate acute glaucoma and convert partial organic pyloric stenosis into complete obstruction. Atropine may also lead to complete urinary retention in patients with prostatic hypertrophy and cause the thickening of bronchial secretions and formation of viscid plugs in patients with chronic lung disease.

Mechanism of Action · 1 item

Atropine binds to and inhibits muscarinic acetylcholine receptors, competitively blocking the effects of acetylcholine and other choline esters. It acts as a reversible non-specific antagonist of muscarinic receptors, showing affinity for the M1, M2, M3, M4 and M5 receptor subtypes. Atropine antagonizes the effects of acetylcholine on tissues innervated by postganglionic cholinergic nerves, such as smooth muscle, cardiac tissue, exocrine glands and the central nervous system. Also, it acts in less innervated smooth muscle that responds to endogenous acetylcholine. The actions of atropine can be overcome by increasing the concentration of acetylcholine at receptor sites (for instance, the use of anticholinesterase agents that inhibit the hydrolysis of acetylcholine).

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
form
powder
pka
9.7 · 9.7(at 21℃)
color
white
Water Solubility
1.6 g/L · 1.6g/L(18 ºC)
Sensitive
Light Sensitive
Merck
14 · 14,875
BRN
91260 · 91260
Major Application
pharmaceutical
InChI
1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16
InChIKey
RKUNBYITZUJHSG-SPUOUPEWSA-N
SMILES
CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c3ccccc3
CAS DataBase Reference
51 · 51-55-8(CAS DataBase Reference)
FDA 21 CFR
310.545 · 310.545
EWG's Food Scores
1 · 1-5
FDA UNII
7 C0697DR9I · 7C0697DR9I
ATC code
3 BA01,A03BA03,S01FA01 · A03BA01,A03BA03,S01FA01
NIST Chemistry Reference
Atropine(51-55-8)
EPA Substance Registry System
Atropine (51-55-8)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
300 · H300+H330
Precautionary statements
260 · P260-P264-P270-P271-P284-P304+P340+P310
Hazard Codes
T+,Xn,F
Risk Statements
26 · 26/28-36/37/38-20/21/22-36-11
Safety Statements
25 · 25-45-36-26-36/37-16
RIDADR
1544 · 1544
WGK Germany
3 · 3
RTECS
700000 · CK0700000
F
8 · 8-10-23
TSCA
TSCA listed
HazardClass
6.1 · 6.1
PackingGroup
III
HS Code
29399900 · 29399900
Storage Class
6.1 A · 6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
Hazard Classifications
2 InhalationAcute · Acute Tox. 2 InhalationAcute Tox. 2 Oral
Hazardous Substances Data
51 · 51-55-8(Hazardous Substances Data)
Toxicity
50 orally · LD50 orally in rats: 750 mg/kg (Cahen, Tvede)
Biological Half-Life · 1 item

Following intravenous and intramuscular doses of atropine, half-life values range from approximately 2 to 4 hours. In geriatric patients (65-75 years old), intravenous atropine has a longer half-life (10 hours). Also, the half-life of atropine is slightly shorter (approximately 20 minutes) in females than in males. In healthy volunteers given 30 µL of atropine sulfate by topical ocular administration, the half-life of atropine was approximately 2.5 hours.

Metabolism/Metabolites · 1 item

Atropine is mainly metabolized by enzymatic hydrolysis in the liver. The major metabolites of atropine are noratropine, atropin-n-oxide, tropine, and tropic acid. The metabolism of atropine is inhibited by organophosphate pesticides.[L42815,​​L42835]

Absorption, Distribution and Excretion · 4 items

Intravenous atropine follows a non-linear pharmacokinetic model at doses between 0.5 and 4 mg. After intramuscular administration, atropine is rapidly absorbed. In adults given 1.67 mg of atropine intramuscularly, the Cmax was 9.6 ng/mL and the Tmax went from 3 to 60 minutes. In healthy subjects given 30 µL of atropine ophthalmic solution, the Cmax and Tmax were 288 pg/mL and 28 minutes, respectively. Atropine is well absorbed in the gastrointestinal tract and rapidly delivered to systemic circulation. When administered intramuscularly, atropine has a bioavailability of 50%. The AUC0-INF and Cmax of atropine are higher in females than males (15%).

Approximately 13 to 50% of atropine is excreted unchanged in the urine. In healthy volunteers given intravenous atropine, 29% of tropine was excreted in urine, along with 15% of an unidentified metabolite.

Atropine is distributed throughout the body. Following intravenous administration, the total apparent volume of distribution of atropine ranged between 1.0 and 1.7 L/kg.

Following intravenous administration, the total clearance of atropine ranged between 5.9 and 6.8 mL/min/kg. Exercise, before and after intramuscular administration, decreases the clearance of atropine.

Uses & manufacturing

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Applications · 7 items

DescriptionAtropine is a naturally occurring tropane alkaloid extracted from plants of the family Solanaceae including deadly nightshade (A. belladonna). It is a non-selective, competitive antagonist of the muscarinic acetylcholine receptor types M1, M2, M3, M4, and M5 (pKBs range from 8.9-9.8). Atropine increases firing of the sinoatrial node and conduction through the atrioventricular node of the heart, opposes the actions of the vagus nerve, blocks acetylcholine receptor sites, and decreases bronchial secretions. It is classified as an anticholinergic (parasympatholytic) drug and commonly used to dilate the pupils, increase heart rate, reduce salivation and other secretions, and as an antidote against organophosphate poisoning.

DescriptionAtropine is considered to be the most effective antidote for both OP and CB intoxication. By effectively competing with acetylcholine for the same cellular receptors, it prevents overstimulation of the autonomous parasympathetic system. Most importantly, it helps prevent asphixia, the main cause of death. In human subjects, it is customary to constantly infuse atropine in order to maintain optimal concentration throughout recovery from the “cholinergic crisis.” In wildlife rehabilitation, this is impractical and subjects need to be repeatedly injected with atropine.

HistoryMandragora (mandrake) was described for treatment of wounds, gout and sleeplessness and as a love potion in the fourth century BC by Theophrastus. Atropine extracted from the Egyptian henbane was used by Cleopatra in the last century BC to dilate her pupils in the hope that she would appear more alluring. In the Renaissance, women used the juice of the berries of Atropa belladonna to enlarge the pupils of their eyes for cosmetic reasons. It isn’t until the first century AD that Dioscorides found that wine containing mandrake can be used as an anaesthetic treatment for pain or sleeplessness in surgery or cautery. The combination of extracts containing tropane alkaloids and opium was used to treat diseases, which was popular in the Roman and Islamic Empires and Europe. The combination was replaced by the use of ether, chloroform and other modern anaesthetics about 100years ago. The mydriatic effects of atropine were studied by the German chemist Friedlieb Ferdinand Runge (1795–1867). In 1831, the German pharmacist Heinrich F. G. Mein (1799–1864) succeeded in separating pure atropine from plants. The substance was first synthesized by German chemist Richard Willsttter in 1901. In 1889, Richard Willsttter first confirmed the chemical structure of atropine. Atropine was first synthesized by A.Ladenburg. Homatropine, a kind of tropic alkaline ester, is used in the diagnosis and treatment in ophthalmology, and it has a shorter acting time than atropine. Quaternary ammonium compounds of atropine obtained by alkylation of nitrogen atoms have anticonvulsant function, which does not affect the central nervous system, due to their polarity. In 1970, atropine sulphate was synthesized in Hangzhou, the location of the first pharmaceutical factory in China, which increased the yield, reduced the cost and met the requirements of clinics.

Usesanticholinergic, mydriatic

UsesAtropine is used in medicine and is an antidote for cholinesteraseinhibiting compounds, such as organophosphorus insecticides and certain nerve gases. Atropine is commonly offered as the sulfate. Atropine is used in connection with the treatment of disturbances of cardiac rhythm and conductance, notably in the therapy of sinus bradycardia and sick sinus syndrome. Atropine is also used in some cases of heart block. In particularly high doses, atropine may induce ventricular tachycardia in an ischemic myocardium. Atropine is frequently one of several components in brand name prescription drugs.

UsesScopolamine is found in the leaves of Daturametel L., D. meteloides L., and D. fastuosavar. alba (Cordell 1978). It is used as asedative, a preanesthetic agent, and in thetreatment of motion sickness (Merck 1989).

General DescriptionAtropine is the tropine ester of racemictropic acid and is optically inactive. It possibly occurs naturallyin various Solanaceae, although some claim, with justification,that whatever atropine is isolated from naturalsources results from racemization of (-)-hyoscyamine duringthe isolation process. Conventional methods of alkaloidisolation are used to obtain a crude mixture of atropine andhyoscyamine from the plant material. This crude mixture isracemized to atropine by refluxing in chloroform or by treatmentwith cold dilute alkali. Because the racemizationprocess makes atropine, an official limit is set on thehyoscyamine content by restricting atropine to a maximumlevorotation under specified conditions.Atropine occurs in the form of optically inactive, white,odorless crystals possessing a bitter taste. It is not very solublein water (1:460, 1:90 at 80°C) but is more soluble inalcohol (1:2, 1:1.2 at 60°C). It is soluble in glycerin (1:27),in chloroform (1:1), and in ether (1:25). Saturated aqueoussolutions are alkaline in reaction (pH 9.5). The free baseis useful when nonaqueous solutions are to be made, such asin oily vehicles and ointment bases. Atropine has a plasmahalf-life of about 2 to 3 hours. It is metabolized in the liverto several products, including tropic acid and tropine.

Upstream & downstream products

Upstream raw materials

Chloroform

Downstream products

Atropine sulfate monohydrateendo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetateATROPINE METHYL NITRATE

Additional notes

DefinitionAn alkaloid that is the 3(s)-endo isomer of atropine.

Definitionatropine: A poisonous crystalline alkaloid,C17H23NO3; m.p. 118–119°C. Itcan be extracted from deadly nightshadeand other solanaceous plantsand is used in medicine to treat colic,to reduce secretions, and to dilatethe pupil of the eye.